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Key Clinical Message
A 27-month-old female cat was presented with septic peritonitis secondary to a
ruptured pyometra and subsequent pyothorax. Vasopressor-refractory septic
shock led to a suspicion of critical illness-related corticosteroid insufficiency,
successfully treated with intravenous hydrocortisone. Previous megestrol acetate
administration may have played a role in the development of adrenocortical
dysfunction.
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Introduction
The syndrome of critical illness-related corticosteroid
insufficiency (CIRCI), previously known as relative adre-
nal insufficiency, is defined as an endocrinological dys-
function in critically ill patients, resulting in inadequate
cortisol activity for the existing severity of illness and
leading to fluid- and vasopressor-refractory shock [1–3].
It may result from alterations in one or more levels of the
hypothalamic–pituitary–adrenal (HPA) axis and glucocor-
ticoid metabolism pathways or from decreased glucocorti-
coid receptor sensitivity and tissue response to
corticosteroids [4–8]. However, its multifactorial patho-
physiology is only partially understood, and there is no
absolute consensus regarding criteria for the diagnosis of
CIRCI in either human or veterinary medicine. The Sur-
viving Sepsis Campaign recommends considering a
patient to be affected by CIRCI if vasopressor-resistant
shock is responsive to supplementation with hydrocorti-
sone [9].
This study is the first case describing suspected CIRCI
in a cat with septic shock and its successful treatment
with hydrocortosone constant rate infusion (CRI).
Case Presentation
A 27-month-old, nulliparous Maine Coon queen was pre-
sented to the Emergency Service of the Small Animal
Hospital of the Vetsuisse Faculty of the University of
Bern, Switzerland with a two-week history of progressive
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anorexia, lethargy, and weight loss. Heat cycle control
with megestrol acetate (MA, 5 mg/cat PO every other
week, in irregular intervals) was last administered
2 months earlier. The cat was presented in lateral recum-
bency, unable to stand with a heart rate of 180 beats/min,
weak peripheral pulses, pale mucous membranes, capillary
refill time of 2 sec, and a rectal temperature of 104°F
(40°C). Severe dehydration, a poor body condition score
of 2/9 and a positive fluid sign on abdominal palpation
were noted. The oscillometric mean arterial blood pres-
sure (oMAP) was 85 mmHg (Fig. 1).
Venous blood gas analysis revealed a mixed acid-base
disorder with pH 7.43 (reference interval [RI], 7.28–7.41),
metabolic acidosis (bicarbonate, 14.1 mmol/L; RI, 18.0–
23.2 mmol/L) respiratory alkalosis (pCO2, 21.8 mmHg; RI,
32.7–44.7 mmHg), and hyperlactatemia (50.5 mg/dL
[5.6 mmol/L]; RI, 0–18.0 mg/dL [0–2.0 mmol/L]). A CBC
revealed leukopenia (1.52 9 103/lL; RI, 6.5–15.4 9 103/
lL), neutropenia (0.33 9 103/lL; RI, 2.5–12.5 9 103/lL)
with a left shift (0.91 9 103/lL; RI, 0–0.3 9 103/lL) and
lymphopenia (0.24 9 103/lL; RI, 1.5–7.0 9 103/lL). A
biochemistry profile revealed hyponatremia (132 mmol/L;
RI, 144–159 mmol/L), hypokalemia (2.94 mmol/L; RI,
3.11–4.93 mmol/L), hypoglycemia (41.4 mg/dL [2.3
mmol/L]; RI, 57.1–102.8 mg/dL [3.17–5.71 mmol/L]),
hyperglobulinemia (4.2 g/dL [42.2 g/L]; RI, 2.7–3.6 g/dL
[27.4–35.5 g/L]), and hypoalbuminemia (1.0 g/dL [10.1 g/
L]; RI, 3.0–4.1 g/dL [30.3–40.5 g/L]). Feline leukemia and
feline immunodeficiency virus serologic tests were negative.
An abdominal focused assessment with sonography for
trauma scan revealed a moderate amount of echogenic fluid
with small suspended particles, diagnosed as a septic exu-
date on cytology and later confirmed with bacteriologic
culture to contain E. coli.
Initial medical management included two boli at
1.4 mL/kg of 25% dextrose, IV isotonic crystalloids
(Plasma-Lyte A, Baxter AG, Volketswil, Switzerland) given
as a 15 mL/kg bolus, followed by 10–15 mL/kg/h constant
rate infusion (CRI) supplemented with 4.5% dextrose and
40 mmol/L KCl, two boli of methadone (0.2 mg/kg IV),
ampicillin–sulbactam (30 mg/kg q8 h IV), metronidazole
(12.5 mg/kg q12 h IV), marbofloxacin (4 mg/kg q24 h
IV), and 20% human serum albumin (27 mL/kg IV over
2.5 h). Two hours after initiating fluid therapy, the heart
rate was 180 beats/min with weak peripheral pulses, and
mucous membranes were pale pink with a capillary refill
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Figure 1. Time-related changes in arterial blood pressure in association with intravenous fluid therapy and administration of vasopressors and
hydrocortisone in a cat with suspected CIRCI. Systolic oscillometric arterial pressures are shown as black triangles, mean oscillometric arterial
pressures as black circles and diastolic oscillometric arterial pressures as black squares. Doppler arterial pressure is shown as white diamonds. Total
volumes of intravenous fluids are shown as gray bars. Vasopressors and hydrocortisone are shown as black arrows. The hydrocortisone bolus is
shown as a black diamond. The red area represents the duration of the general anesthesia.
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time of 2 sec. The oMAP decreased to 60 mmHg (Fig. 1).
The hematocrit was 24%, total solids—55 g/L and blood
glucose—220 mg/dL (12.2 mmol/L). A full abdominal
exploratory laparotomy revealed approximately 200 mL
of fluid, a ruptured pyometra, and generalized peritonitis.
An ovariohysterectomy was performed, the abdomen was
copiously lavaged, and Jackson Pratt drains were placed
prior to abdominal closure. The anesthetic protocol con-
sisted of premedication with methadone (0.1 mg/kg IV)
and midazolam (0.2 mg/kg IV), and induction with alfax-
alone (1 mg/kg IV). Following endotracheal intubation,
anesthesia was maintained using isoflurane (1.1–1.3%) in
100% oxygen. Intraoperative analgesia was provided with
fentanyl (5–10 lg/kg/h IV).
Persistent intra-operative hypotension (median Doppler
systolic arterial pressure, 50 mmHg; range, 35–60 mmHg)
was observed despite fluid resuscitation (55 mL/kg over
3 h) and dopamine CRI (6–10 lg/kg/min, Fig. 1). Hypo-
glycemia (60 mg/dL [3.3 mmol/L]) despite supplementa-
tion and hyperlactatemia (36 mg/dL [4 mmol/L])
recurred. Hypotension continued in the postoperative
period (oMAP, 58.5 mmHg; range, 45–89 mmHg) despite
continued dopamine CRI. Supplementation with titrating
CRI doses of noradrenaline (0.001–0.5 lg/kg/min)
resulted in minimal transient improvement (Fig. 1).
Immediately following surgery, the hematocrit was 26%,
total solids—58 g/L, blood glucose—80 mg/dL
(4.4 mmol/L), and blood lactate—42.3 mg/dL (4.7 mmol/
L). Critical illness-related corticosteroid insufficiency
(CIRCI) was suspected based on persistent hypotension
unresponsive to fluid therapy (total fluid volume,
130 mL/kg over 10 h) and to vasopressors (Fig. 1) despite
high basal cortisol concentrations at presentation
(10.4 lg/dL; RI, 0.5–8.80 lg/dL). Hydrocortisone was
administered IV (initial bolus of 1 mg/kg followed by
0.16 mg/kg/h CRI). Normotension (oMAP, 86 mmHg;
range, 70–94 mmHg), correction of hypoglycemia and an
improvement in the general condition of the cat were
observed within 3 h and maintained throughout the hos-
pitalization (Fig. 1). Intravenous supplementation with
dextrose and vasopressor therapy was tapered and discon-
tinued over 3 and 16 h, respectively. Hydrocortisone ther-
apy was reduced by 50% every 48 h and discontinued
over 5 days.
One day after surgery, the cat developed mild dysp-
nea. A thoracic ultrasound revealed minimal pleural and
pericardial effusions. Echocardiography revealed mild
inhomogeneity of the ventricular wall, suggestive of pos-
sible myocarditis, and minimal pericardial effusion. Pleu-
ral fluid real-time PCR for feline Corona virus was
negative. Cytology revealed a septic exudate, confirmed
to be hemolytic E. coli on bacterial culture. Blood cul-
tures were negative. The pyothorax was treated with
intermittent thoracocentesis followed by placement of
bilateral chest drains and intermittent lavage during
4 days. Bacterial culture and sensitivity revealed that
E. coli cultured from both body cavities was sensitive to
marbofloxacin but E.coli cultured from the peritoneal
cavity was resistant to ampicillin and rifampicin, and E.-
coli cultured from the pleural cavity was resistant to all
penicillins and 1st- and 3rd-generation cephalosporins.
Monotherapy with marbofloxacin was, therefore,
continued.
Outcome and Follow-up
The cat was discharged 14 days after presentation in good
general condition with a good appetite and a body condi-
tion score of 3/9 with instructions to continue adminis-
tration of oral marbofloxacin (4 mg/kg q24 h) for a
further 10 days. On follow-up examination 1 month later,
the cat had a body condition score of 4/9, and no clinical
abnormalities were noted. Echocardiography revealed per-
sistence of myocardial changes but no functional abnor-
malities.
Three months later, the cat was presented because of
acute lethargy in lateral recumbency with a rectal temper-
ature of 91.4°F (33.1°C) and dehydration. Emergency
blood work revealed a high packed cell volume (58%; RI,
27–47%) and total solids (11.6 g/dL [116 g/L]; RI, 5.5–
7.6 g/dL [55–76 g/L]), elevated plasma creatinine
(3.3 mg/dL [287 lmol/L]; RI, 0.8–2.4 mg/dL [71–
212 lmol/L]), and hypoglycemia (55.8 mg/dL [3.1 mmol/
L]). Venous blood gas analysis revealed acidemia (pH,
7.13), metabolic acidosis (bicarbonate, 12.8 mmol/L), and
hyperlactatemia (68.5 mg/dL [7.6 mmol/L]). The cat was
treated with IV crystalloids supplemented with dextrose
but suffered cardiopulmonary arrest within a few hours
of presentation. Cardiopulmonary resuscitation was not
attempted as the owner had requested a do not resuscitate
order.
Necropsy, performed with the owner’s consent,
revealed mild myocardial arteriosclerosis, and bilateral
diffuse adrenocortical hyperplasia and hypertrophy with
moderate cytoplasmic vacuolization, but no lesions
explaining the cause of death were identified.
Discussion
Reports of CIRCI in veterinary literature are limited to
rare case reports and evaluation of the HPA axis in small
groups of critically ill animals. In most veterinary publica-
tions, evaluation of HPA-axis impairment was based on
delta cortisol values (the difference in cortisol concentra-
tions before and after administration of adrenocorti-
cotropic hormone [ACTH]) [10]. Lower delta cortisol
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values and higher free cortisol fractions were reported in
six dogs with septic shock compared to healthy controls
[11]. In one study, dogs with severe trauma, sepsis or gas-
tric dilation-volvulus were found to have decreased delta
cortisol values compared to controls. Furthermore, dogs
with lower delta cortisol values were more likely to
receive vasopressors [12]. In another report, both
hypotension and decreased survivals were found to be
associated with lower delta cortisol values in septic dogs
[13]. Decreased delta cortisol levels were additionally
reported in a small population of critically ill cats [14].
Despite such reports in the veterinary literature, current
recommendations in human medicine do not support use
of the ACTH-stimulation test to identify patients with
CIRCI requiring corticosteroid treatment [4, 9, 15].
Instead, CIRCI is suspected when fluid therapy and vaso-
pressor-resistant shock (usually failure to maintain SAP >
90 mmHg or MAP > 65 mmHg) are responsive to
hydrocortisone administration [4, 15, 16]. Likewise, the
diagnosis of suspected CIRCI in the cat in the present
report was based on clinical findings and response to
therapy.
Previous reports of treatment of suspected CIRCI in
veterinary medicine include a dog with hydrocortisone-
responsive septic shock [17] and a cat with polytrauma-
related hypotension responsive to intravenous dexam-
ethasone [18]. Additionally, one abstract reports a
prospective blinded placebo-controlled study in eight
dogs treated with either hydrocortisone or an equivalent
volume of saline, but results were inconclusive due to
the small number of dogs enrolled [19]. While intermit-
tent and CRI administration of hydrocortisone appear to
be equally effective in people with CIRCI, dexam-
ethasone is not recommended due to its prolonged sup-
pression of the HPA axis [4]. Although different
hydrocortisone treatment regimens have been reported
in both veterinary and human medicine [3, 4, 9, 10,
20], the ultimate goal of therapy is to provide doses of
hydrocortisone adequate for the needs of the patient.
The cat in the present report was treated with a dose
suggested in both human [4] and veterinary literature
[21], as evidence-based therapeutic guidelines for cats
are lacking.
Basal cortisol levels in the cat in the present report
were above reference ranges, similar to previous reports
in critically ill dogs and cats [11, 14] but in contrast to
the normal levels found in the previously reported poly-
traumatized cat with suspected CIRCI [18]. However, as
CIRCI may result from different aspects of HPA axis
impairment, including tissue resistance or decreased
receptor sensitivity, basal cortisol levels may be above or
below reference ranges and be insufficient to meet the
needs of the patient [2, 4, 11].
Although CIRCI has mostly been associated with septic
shock, other causes including traumatic brain injury and
cancer have been reported in people [22–24]. Similarly,
the previously reported case of feline CIRCI was a cat
with polytrauma [18]. In addition, evidence of CIRCI
based on ACTH-stimulation testing was found in criti-
cally ill cats with neoplasia [25]. Septic shock was likely
the main cause of CIRCI in the cat reported here, but
predisposing factors, including drug exposure should be
considered [26, 27]. Megestrol acetate administration has
been associated with metropathies [28–30], and likely
played a role in the development of pyometra in this cat.
Moreover, MA administration may lead to reversible and
potentially fatal HPA axis suppression in both humans
and cats [31–34], thereby implicating it in the develop-
ment of CIRCI itself. However, adrenocortical recovery
after MA administration (2.5 mg/cat q24 h or 5 mg/cat
q48 h for 2 weeks) was found to only require 2–4 weeks
[34–36]. The cat in the present report received a similar
dose and the last dose reported by the owner was 8 weeks
prior presentation. Even if the owner was mistaken about
the timing of the last dose of MA, basal cortisol would be
expected to be <1 lg/mL in MA-induced HPA axis sup-
pression [34], but basal cortisol measured in this cat was
elevated. Moreover, hydrocortisone therapy is considered
necessary in people with CIRCI regardless of cause, and
treatment response in this cat is evidence of CIRCI
responding to hydrocortisone whether or not MA played
a role in its development [33].
The use of alfaxalone, a synthetic allopregnanolone
analog as an anesthesia induction agent, might have inter-
fered with the HPA axis in this patient. Indeed, allopreg-
nanolone may increase production of endogenous
opioids, which downregulate corticotropin-releasing hor-
mone production by presynaptic inhibition of nora-
drenaline release [37, 38]. Nevertheless, alfaxalone failed
to induce HPA suppression in ovario-hysterectomized
sows as opposed to endogenous allopregnanolone in preg-
nant sows [39]. Furthermore, alfaxalone was reported to
increase cortisol levels in anesthetized rabbits [40], and an
alfaxalone/alfadolone mixture has been reported to
increase cortisol levels in rats and people [41, 42]. To the
authors’ knowledge, the effects of alfaxalone on the HPA
axis in cats have not been investigated. Moreover, as
hypotension was observed prior to anesthesia, alfaxalone
administration is unlikely to have caused CIRCI in the
cat described in this report.
Although reports on histopathologic findings in CIRCI
patients are rare, severe adrenal hemorrhage secondary to
bacterial infection (Waterhouse–Friderichsen syndrome),
most commonly to meningococcal sepsis, is described in
humans and has been associated with the development of
CIRCI [43, 44]. In the case described herein, necropsy
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revealed bilateral diffuse adrenocortical hyperplasia and
hypertrophy, which has previously been associated with
chronic stress [45], pituitary hyperadrenocorticism [46,
47], hyperaldosteronism [48], and congenital adrenal
hyperplasia [49]. Although ACTH-stimulation testing is
not considered useful during initial shock management, a
convalescent ACTH-stimulation test may, therefore, have
been of benefit to investigate adrenal function in this case.
The failure to perform an ACTH-stimulation test when
the cat presented for follow-up examination is, therefore,
a limitation of this report. Necropsy also revealed adreno-
cortical cytoplasmic vacuolization, which has been
described in association with toxicosis [50] and MA
administration [34]. However, reversible adrenocortical
atrophy rather than hyperplasia would be expected if vac-
uolization was due to MA or hydrocortisone administra-
tion [34]. Whether the observed histopathologic changes
were secondary to CIRCI or an underlying disease predis-
posing to CIRCI in this case remains unclear. Further-
more, as necropsy was performed 2 months after initial
presentation, the observed histopathologic findings may
be unrelated to the presenting sepsis, shock, or CIRCI.
Indeed, no macroscopic adrenal changes were observed
during laparotomy, although abdominal exploration may
have been limited due to hypotension and the desire to
curtail the duration of anesthesia. To the authors’ knowl-
edge, necropsy findings of adrenal glands of animals with
suspected CIRCI have not been previously reported.
In conclusion, this is the first report of suspected
CIRCI in a cat with septic shock treated successfully
with hydrocortisone. Critical illness-related corticosteroid
insufficiency should be recognized as a potential cause
of fluid- and vasopressor-refractory septic shock in cats,
and treatment with hydrocortisone considered in such
cases. Although unclear in this case, prior exposure to
MA and other drugs that may affect the HPA axis
could potentially contribute to the development of
CIRCI.
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